Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 6/20 | 0.54 |
| ▸ | RAB9A | P51151 | 6/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.54 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.54 |
| ▸ | PPARA | Q07869 | 4/20 | 0.49 |
| ▸ | ILK | Q13418 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NQO2 | P16083 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30627231 | 1.00 | NPC1 (0.54) | NPC1RAB9ASMN1; SMN2DYRK1APPARA | |
| SCHEMBL9157816 | 0.88 | PPARA (0.53) | NPC1RAB9ASMN1; SMN2DYRK1APPARA | |
| SCHEMBL5923359 | 0.86 | CYP1A2 (0.65) | NPC1RAB9ASMN1; SMN2DYRK1ACYP1A2 | |
| 2-Mercaptobenzothiazole SCHEMBL2172823 | 0.85 | PDE10A (0.49) | NPC1RAB9ASMN1; SMN2DYRK1AILK | |
| Methane SCHEMBL2171653 | 0.85 | PDE10A (0.49) | NPC1RAB9ASMN1; SMN2DYRK1AILK | |
| SCHEMBL6692946 | 0.81 | KMT2A (0.51) | NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4 | |
| SCHEMBL31276816 | 0.80 | NPC1 (0.55) | NPC1RAB9ASMN1; SMN2DYRK1APPARA | |
| SCHEMBL2400142 | 0.80 | NPC1 (0.55) | NPC1RAB9ASMN1; SMN2DYRK1APPARA | |
| SCHEMBL95067 | 0.80 | NPC1 (0.55) | NPC1RAB9ASMN1; SMN2DYRK1APPARA | |
| SCHEMBL6690420 | 0.79 | ATP4A (0.44) | NPC1RAB9ASMN1; SMN2CYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12575418-B2 | Semiconductor packages having organic material layer between through-via structure and encapsulant that surrounds a portion of semiconductor chip | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-03-10 | — | — | US | claimed |
| US-20240006342-A1 | SEMICONDUCTOR PACKAGES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-01-04 | — | — | US | claimed |
| CN-117286499-A | Copper etching solution | 福建钰融科技有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-113754650-B | High-selectivity synthesis method of rosuvastatin calcium intermediate | 湖北宇阳药业有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-116623186-A | Corrosion inhibitor for inhibiting electrochemical corrosion and preparation method thereof | 范斌磊 | 2023-08-22 | — | — | CN | claimed |
| CN-113754650-A | High-selectivity synthesis method of rosuvastatin calcium intermediate | 湖北宇阳药业有限公司 | 2021-12-07 | — | — | CN | claimed |
| CN-113045993-A | Polishing solution for processing ultra-smooth low-damage bearing steel surface and application thereof | 西南交通大学 | 2021-06-29 | — | — | CN | claimed |
| US-20040018983-A1 | Antifungal compositions | ACHILLION PHARMACEUTICALS, INC. | 2004-01-29 | — | — | US | claimed |
| WO-2003055448-A2 | ANTIFUNGAL COMPOSITIONS | ACHILLION PHARMACEUTICALS, INC. (US) | 2003-07-10 | — | — | WO | claimed |
| US-12575418-B2 | Semiconductor packages having organic material layer between through-via structure and encapsulant that surrounds a portion of semiconductor chip | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-03-10 | — | — | US | disclosed |
| CN-117677675-B | Halogenated phthalocyanine color material, colored curable composition, color filter, and display device | DNP精细化工股份有限公司 | 2026-02-27 | — | — | CN | disclosed |
| US-20260022122-A1 | NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME | CHECKMATE THERAPEUTICS INC. (KR) | 2026-01-22 | — | — | US | disclosed |
| US-20250333417-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2025-10-30 | — | — | US | disclosed |
| US-12422749-B2 | Photosensitive ink composition, cured product, display panel, and method for producing cured product | TOKYO OHKA KOGYO CO., LTD. (JP) | 2025-09-23 | — | — | US | disclosed |
| EP-0430115-A1 | Radiographic elements with improved covering power | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-06-05 | — | — | EP | disclosed |
| EP-0129506-B1 | HETEROCYCLICALLY SUBSTITUTED THIO(CYCLO)ALKANE POLYCARBOXYLIC ACIDS | CIBA-GEIGY AG (CH) | 1991-03-06 | — | — | EP | disclosed |
| US-4740596-A | Process for preparation of 4-sulfonylthio azetidinone derivatives | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1988-04-26 | — | — | US | disclosed |
| US-4713452-A | Process for preparation of azetidinone derivatives | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1987-12-15 | — | — | US | disclosed |
| EP-0129506-A2 | Heterocyclically substituted thio(cyclo)alkane polycarboxylic acids | CIBA-GEIGY AG (CH) | 1984-12-27 | — | — | EP | disclosed |
| US-4454148-A | 5-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure | MERCK & CO., INC. (US) | 1984-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040018983-A1 | Antifungal compositions | CNBP, ERG28, AEBP2 | NPC1 1211/4885RAB9A 4220/4885SMN1; SMN2 4019/4885 |
| US-20250333417-A1 | IRAK DEGRADERS AND USES THEREOF | IRAK2, IRAK3, IRAK1 | NPC1 3159/4885RAB9A 4270/4885SMN1; SMN2 2647/4885 |
| US-12575418-B2 | Semiconductor packages having organic material layer between through-via structure and encapsulant that surrounds a portion of semiconductor chip | MTAP, TPMT, PIM2 | NPC1 4430/4885RAB9A 4249/4885SMN1; SMN2 2437/4885 |
| US-20260022122-A1 | NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME | NAMPT, NAPRT, NNT | NPC1 57/4885RAB9A 1585/4885SMN1; SMN2 2571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.